Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Health Lab
Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation.
News Release
Increased understanding of the genetic mutations that drive non-small cell lung cancer has led to new, effective treatments in recent years.
Health Lab
A clearer picture of how a cell is organized could help biologists learn how to reprogram a cell to halt cancer or other diseases.
News Release
The University of Michigan Board of Regents approved the appointment at its Sept. 22 meeting. Chang, who is currently the Sue and Bob McCollum Professor of Radiation Oncology at Stanford University, will begin at U-M on Oct. 1.
Health Lab
GOT2 causes metabolic changes that pancreas tumors overcome.
Medicine at Michigan
The prize is awarded by the Royal Swedish Academy of Sciences, which also awards Nobel Prizes
Health Lab
The approach, studied in mice, overcomes the blood brain barrier and breaks the shield tumors build against the immune response.
Health Lab
Crowdfunding to pay medical bills has become increasingly common in the United States. A new study highlights the impact crowdfunding for health care costs has had on young cancer survivors.
News Release
Arul M. Chinnaiyan, M.D., Ph.D., S.P. Hicks Professor of Pathology and Urology at Michigan Medicine, was awarded the 2022 Sjöberg Prize by the Royal Swedish Academy of Sciences, which also awards Nobel Prizes.
Health Lab
Nearly 2 decades after a groundbreaking discovery, Arul Chinnaiyan wins a prestigious cancer research award.
Health Lab
A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.
Health Lab
HPV circulating tumor DNA and MRI/PET imaging markers predicted which tumors would respond to chemoradiation as early as two weeks into treatment.
Health Lab
New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.
Health Lab
A new perspective looks at the built-in bias within the factors that drive physicians’ salaries and makes recommendations for how institutions can close the gap.
Health Lab
In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.
